Hearing Diagnostics Center Pc Audiologist Medicare: Medicare Enrolled Practice Location: 1206 College Ave, Suite 1, Goshen, IN 46526 Phone: 574-534-4171 Fax: 574-533-3466 |
Darah Jean Regal, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2012 S Main St Ste B, Goshen, IN 46526 Phone: 574-534-2025 Fax: 574-534-2042 |
Family Hearing Center, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2134 College Ave, Goshen, IN 46528 Phone: 574-533-2222 Fax: 574-533-6868 |
Dr. David Courtland Craig, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1206 College Ave, Suite 1, Goshen, IN 46526 Phone: 574-534-4171 Fax: 574-533-3466 |
Hearing Diagnostics Center Pc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1206 College Ave, Suite 1, Goshen, IN 46526 Phone: 574-534-4171 |
Dr. Suzanne Rene Ginter, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2134 College Ave, Goshen, IN 46528 Phone: 574-533-2222 Fax: 574-533-6868 |
Chelsea Twyman-douglas, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2606 Peddlers Village Rd, Goshen, IN 46526 Phone: 260-602-3276 |
News Archive
The Keck School of Medicine of the University of Southern California has announced a $24 million charitable gift from media executive and philanthropist Sumner M. Redstone. The multi-million dollar gift will support cancer research directed by renowned oncologist David Agus, M.D., professor of medicine at the Keck School of Medicine of USC and director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center.
Researchers at the University of California San Diego discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer's disease.
A new, $17.8 million grant will ensure USC remains at the forefront of research to protect people from tobacco-related health risks.
PolyMedix, Inc, an emerging biotechnology company focused on developing new therapeutic drugs to treat life-threatening infectious diseases and acute cardiovascular disorders, announced that data from two Phase 1B/2 clinical studies with PMX-60056 were presented today, in oral and poster sessions, at the Annual American Heart Association Scientific Sessions Meeting. PMX-60056 is a synthetic, small-molecule designed to reverse the anti-clotting effects of both heparin and low molecule weight heparin (LMWH).
Children could have their cholesterol levels tested at about 15 months of age to prevent heart disease later in life, say doctors in a study published on bmj.com today.
› Verified 2 days ago